vitiligo chronic autoimmune disorder causes patches skin lose pigment cause vitiligo unknown may related immune system changes genetic factors stress sun treatment options include topical medications light therapy surgery sign vitiligo presence pale patchy areas depigmented skin tend occur people may experience itching new patch patches initially small often grow change skin lesions occur prominent face hands loss skin pigmentation particularly noticeable around body orifices mouth eyes nostrils genitalia lesions increased skin pigment around affected vitiligo stigmatized condition may experience depression similar mood vitiligo lighter skin nonsegmental vitiligo dark skin nonsegmental vitiligo eyelids although multiple hypotheses suggested potential triggers cause vitiligo studies strongly imply changes immune system responsible vitiligo proposed multifactorial disease genetic susceptibility environmental factors thought play hypothesized damaging environmental factors disrupt redox reactions necessary protein folding skin cells may initiate unfolded protein response releases cytokines thus mounting immune response national institutes health states believe sunburns cause exacerbate condition idea wellsupported good melanin pigment gives skin color produced skin cells called melanocytes variations genes part immune system part melanocytes associated also thought caused immune system attacking destroying melanocytes genome wide association study found approximately independent susceptibility loci generalized tyr gene encodes protein tyrosinase component immune system enzyme melanocyte catalyzes melanin biosynthesis major autoantigen generalized vitiligo sometimes associated autoimmune inflammatory diseases hashimotos thyroiditis scleroderma rheumatoid arthritis type diabetes mellitus psoriasis addisons disease pernicious anemia alopecia areata systemic lupus erythematosus celiac among inflammatory products caspase caspase activate inflammatory cytokine expressed high levels people one mutations amino acid leucine protein replaced histidine original protein sequence highly conserved evolution found humans chimpanzee rhesus monkey bush baby addisons disease typically autoimmune destruction adrenal glands may also seen individuals ultraviolet light used early phase disease identification determine effectiveness using woods light skin change colour fluoresce affected certain bacteria fungi changes pigmentation classification attempts quantify vitiligo analyzed somewhat recent consensus agreed system segmental vitiligo sv nonsegmental vitiligo nsv nsv common type nonsegmental vitiligo nsv usually form symmetry location patches depigmentation new patches also appear time generalized large portions body localized particular area extreme cases vitiligo extent little pigmented skin remains referred vitiligo universalis nsv come age unlike segmental vitiligo far prevalent teenage classes nonsegmental vitiligo include following segmental vitiligo sv differs appearance cause frequency associated illnesses treatment different nsv tends affect areas skin associated dorsal roots spinal cord often much stablestatic course association autoimmune diseases appears weaker generalized sv improve topical therapies uv light however surgical treatments cellular grafting chemical leukoderma similar condition due multiple exposures vitiligo however risk triggers may include inflammatory skin conditions burns intralesional steroid injections conditions similar symptoms include following cure vitiligo several treatment options best evidence applied steroids ultraviolet light combination due higher risks skin cancer united kingdoms national health service suggests phototherapy used primary treatments lesions located hands feet joints difficult repigment face easiest return natural skin color skin thinner topical preparations immune suppressing medications including glucocorticoids clobetasol betamethasone calcineurin inhibitors tacrolimus pimecrolimus considered firstline vitiligo july ruxolitinib cream sold brand name opzelura approved medical use united states treatment phototherapy considered secondline treatment exposing skin light uvb lamps common treatment vitiligo treatments done home uvb lamp clinic exposure time managed skin suffer overexposure treatment take weeks spots neck face existed years spots hands legs years take months phototherapy sessions done times week spots large area body may require full body treatment clinic hospital uvb broadband narrowband lamps narrowband ultraviolet peaked around nm choice constitutively reported combination uvb phototherapy topical treatments improves repigmentation however people vitiligo may see changes skin repigmentation occurring serious potential side effect involves risk developing skin cancer risk overexposure natural sunlightcitation needed ultraviolet light uva treatments normally carried hospital clinic psoralen ultraviolet light puva treatment involves taking drug increases skins sensitivity ultraviolet light exposing skin high doses uva light treatment required twice week months longer high doses uva psoralen puva may cause side effects sunburntype reactions skin narrowband ultraviolet b nbuvb phototherapy lacks sideeffects caused psoralens effective puva treatment carried twice weekly clinic every day home need use longer treatment often recommended least months may required effects nbuvb phototherapy appears better puva therapy effective response face respect improved repigmentation topical calcineurin inhibitors plus phototherapy better phototherapy hydrocortisone plus laser light better laser light alone ginkgo biloba better placebo oral minipulse prednisolone omp plus nbuvb better omp mild cases vitiligo patches hidden makeup cosmetic camouflage solutions affected person paleskinned patches made less visible avoiding tanning unaffected cases extensive vitiligo option depigment unaffected skin topical drugs like monobenzone mequinol hydroquinone may considered render skin even color removal skin pigment monobenzone permanent vigorous sunsafety must adhered life avoid severe sunburn melanomas depigmentation takes year descriptions disease believed vitiligo date back passage medical text ebers papyrus c bc ancient egypt also hebrew word tzaraath old testament book dating described group skin diseases associated white spots subsequent translation greek led continued conflation vitiligo leprosy spiritual medical sources ancient world hippocrates often differentiate vitiligo leprosy often grouping diseases together name vitiligo first used roman physician aulus cornelius celsus classic medical text de term vitiligo believed derived vitium meaning defect change appearance caused vitiligo affect persons emotional psychological wellbeing may create difficulty becoming remaining employed particularly vitiligo develops visible areas body face hands arms participating vitiligo support group may improve social coping skills emotional notable cases include us pop singer michael canadian fashion model winnie new zealand singersongwriter us actor david dastmalchian argentine musician charly garcía professional wrestler bryan french actor michaël youn also former french prime minister édouard tv host model former miss colombia taliana july afamelanotide phase ii iii clinical trials vitiligo skin medication rheumatoid arthritis tofacitinib tested treatment october scientific report published successfully transplanting melanocytes vitiligoaffected areas effectively repigmenting procedure involved taking thin layer pigmented skin persons gluteal region melanocytes separated cellular suspension expanded culture area treated denuded dermabrader melanocytes graft applied percent people vitiligo experienced nearly complete repigmentation skin longevity repigmentation differed person current research suggests janus kinasesignal transducer activator transcription pathway jakstat pathway plays crucial role loss epidermal melanocytes pathway activated cells creating positivefeedback loop interferongamma ifnγ chemokines keratinocytes potentially contributing jak inhibitors like ruxolitinib show promise targeting ifnγchemokine signaling axis implicated vitiligo pathogenesis improving nonsegmental httpsenwikipediaorgwikitrichromevitiligo